0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Vaccine Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-12116
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Veterinary Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Veterinary Vaccine Market Research Report 2024

Code: QYRE-Auto-12116
Report
October 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Vaccine Market Size

The global Veterinary Vaccine market was valued at US$ 11540 million in 2023 and is anticipated to reach US$ 18540 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.

Veterinary Vaccine Market

Veterinary Vaccine Market

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Factors influencing growth in demand for farm vaccines include:
• human population growth and increasing standards of living, particularly in many emerging markets;
• increasing demand for improved nutrition, particularly animal protein;
• natural resource constraints, such as scarcity of arable land, fresh water and increased competition for cultivated land, resulting in fewer resources that will be available to meet this increased demand for animal protein;
• increasing urbanization and increased focus on food safety and food security. Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally.
The primary companion animal species are dogs, cats and horses. Factors influencing growth in demand for companion animal vaccines include:
• economic development and related increases in disposable income, particularly in many emerging markets;
• increasing pet ownership
• companion animals living longer, increasing medical treatment of companion animals and advances in companion animal medicines and vaccines.
North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 30%.
Global key Veterinary Vaccine players cover Merck, Boehringer Ingelheim, Zoetis, Elanco, Ceva, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Virbac, etc. In terms of revenue, the global five largest companies occupied for a share nearly 75.64% in 2023.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Vaccine Market Report

Report Metric Details
Report Name Veterinary Vaccine Market
Accounted market size in 2023 US$ 11540 million
Forecasted market size in 2030 US$ 18540 million
CAGR 6.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Other
Segment by Application
  • Farm Animal
  • Companion Animal
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco, Virbac, Jinyu Bio-Technology, Medion, CAVAC, Kyoto Biken Laboratories, FATRO, Vaksindo, Bio-Labs, Avimex Animal Health, MEVAC, Biovac, Atafen, Dyntec, RVSRI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Veterinary Vaccine Market growing?

Ans: The Veterinary Vaccine Market witnessing a CAGR of 6.9% during the forecast period 2024-2030.

What is the Veterinary Vaccine Market size in 2030?

Ans: The Veterinary Vaccine Market size in 2030 will be US$ 18540 million.

What is the Veterinary Vaccine Market share by region?

Ans: North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023.

Who are the main players in the Veterinary Vaccine Market report?

Ans: The main players in the Veterinary Vaccine Market are Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco, Virbac, Jinyu Bio-Technology, Medion, CAVAC, Kyoto Biken Laboratories, FATRO, Vaksindo, Bio-Labs, Avimex Animal Health, MEVAC, Biovac, Atafen, Dyntec, RVSRI

What are the Application segmentation covered in the Veterinary Vaccine Market report?

Ans: The Applications covered in the Veterinary Vaccine Market report are Farm Animal, Companion Animal

What are the Type segmentation covered in the Veterinary Vaccine Market report?

Ans: The Types covered in the Veterinary Vaccine Market report are Live Attenuated Vaccines, Inactivated Vaccines, Other

1 Veterinary Vaccine Market Overview
1.1 Product Definition
1.2 Veterinary Vaccine by Type
1.2.1 Global Veterinary Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Other
1.3 Veterinary Vaccine by Application
1.3.1 Global Veterinary Vaccine Market Value by Application (2024-2030)
1.3.2 Farm Animal
1.3.3 Companion Animal
1.4 Global Veterinary Vaccine Market Size Estimates and Forecasts
1.4.1 Global Veterinary Vaccine Revenue 2019-2030
1.4.2 Global Veterinary Vaccine Sales 2019-2030
1.4.3 Global Veterinary Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Veterinary Vaccine Market Competition by Manufacturers
2.1 Global Veterinary Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Veterinary Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Veterinary Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Veterinary Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
2.8 Global Veterinary Vaccine Market Competitive Situation and Trends
2.8.1 Global Veterinary Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Vaccine Players Market Share by Revenue
2.8.3 Global Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Vaccine Market Scenario by Region
3.1 Global Veterinary Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Veterinary Vaccine Sales by Region: 2019-2030
3.2.1 Global Veterinary Vaccine Sales by Region: 2019-2024
3.2.2 Global Veterinary Vaccine Sales by Region: 2025-2030
3.3 Global Veterinary Vaccine Revenue by Region: 2019-2030
3.3.1 Global Veterinary Vaccine Revenue by Region: 2019-2024
3.3.2 Global Veterinary Vaccine Revenue by Region: 2025-2030
3.4 North America Veterinary Vaccine Market Facts & Figures by Country
3.4.1 North America Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Veterinary Vaccine Sales by Country (2019-2030)
3.4.3 North America Veterinary Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Vaccine Market Facts & Figures by Country
3.5.1 Europe Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Veterinary Vaccine Sales by Country (2019-2030)
3.5.3 Europe Veterinary Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.5.9 Greece
3.5.10 Ukraine
3.5.11 Moldova
3.5.12 Albania
3.5.13 Serbia
3.6 Asia Pacific Veterinary Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Veterinary Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Veterinary Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary Vaccine Market Facts & Figures by Country
3.7.1 Latin America Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Veterinary Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Veterinary Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Veterinary Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Veterinary Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
3.8.7 Egypt
3.8.8 South Africa
3.8.9 Israel
4 Segment by Type
4.1 Global Veterinary Vaccine Sales by Type (2019-2030)
4.1.1 Global Veterinary Vaccine Sales by Type (2019-2024)
4.1.2 Global Veterinary Vaccine Sales by Type (2025-2030)
4.1.3 Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Veterinary Vaccine Revenue by Type (2019-2030)
4.2.1 Global Veterinary Vaccine Revenue by Type (2019-2024)
4.2.2 Global Veterinary Vaccine Revenue by Type (2025-2030)
4.2.3 Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Veterinary Vaccine Sales by Application (2019-2030)
5.1.1 Global Veterinary Vaccine Sales by Application (2019-2024)
5.1.2 Global Veterinary Vaccine Sales by Application (2025-2030)
5.1.3 Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Veterinary Vaccine Revenue by Application (2019-2030)
5.2.1 Global Veterinary Vaccine Revenue by Application (2019-2024)
5.2.2 Global Veterinary Vaccine Revenue by Application (2025-2030)
5.2.3 Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Veterinary Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Company Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Veterinary Vaccine Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Company Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Veterinary Vaccine Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Company Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CAHIC Veterinary Vaccine Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Company Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HVRI Veterinary Vaccine Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Ringpu Biology
6.7.1 Ringpu Biology Company Information
6.7.2 Ringpu Biology Description and Business Overview
6.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
6.7.5 Ringpu Biology Recent Developments/Updates
6.8 Yebio
6.8.1 Yebio Company Information
6.8.2 Yebio Description and Business Overview
6.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Yebio Veterinary Vaccine Product Portfolio
6.8.5 Yebio Recent Developments/Updates
6.9 DHN
6.9.1 DHN Company Information
6.9.2 DHN Description and Business Overview
6.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 DHN Veterinary Vaccine Product Portfolio
6.9.5 DHN Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Company Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WINSUN Veterinary Vaccine Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Elanco
6.11.1 Elanco Company Information
6.11.2 Elanco Description and Business Overview
6.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elanco Veterinary Vaccine Product Portfolio
6.11.5 Elanco Recent Developments/Updates
6.12 Virbac
6.12.1 Virbac Company Information
6.12.2 Virbac Description and Business Overview
6.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Virbac Veterinary Vaccine Product Portfolio
6.12.5 Virbac Recent Developments/Updates
6.13 Jinyu Bio-Technology
6.13.1 Jinyu Bio-Technology Company Information
6.13.2 Jinyu Bio-Technology Description and Business Overview
6.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
6.13.5 Jinyu Bio-Technology Recent Developments/Updates
6.14 Medion
6.14.1 Medion Company Information
6.14.2 Medion Description and Business Overview
6.14.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Medion Veterinary Vaccine Product Portfolio
6.14.5 Medion Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Company Information
6.15.2 CAVAC Description and Business Overview
6.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 CAVAC Veterinary Vaccine Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Kyoto Biken Laboratories
6.16.1 Kyoto Biken Laboratories Company Information
6.16.2 Kyoto Biken Laboratories Description and Business Overview
6.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
6.16.5 Kyoto Biken Laboratories Recent Developments/Updates
6.17 FATRO
6.17.1 FATRO Company Information
6.17.2 FATRO Description and Business Overview
6.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 FATRO Veterinary Vaccine Product Portfolio
6.17.5 FATRO Recent Developments/Updates
6.18 Vaksindo
6.18.1 Vaksindo Company Information
6.18.2 Vaksindo Description and Business Overview
6.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Vaksindo Veterinary Vaccine Product Portfolio
6.18.5 Vaksindo Recent Developments/Updates
6.19 Bio-Labs
6.19.1 Bio-Labs Company Information
6.19.2 Bio-Labs Description and Business Overview
6.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
6.19.5 Bio-Labs Recent Developments/Updates
6.20 Avimex Animal Health
6.20.1 Avimex Animal Health Company Information
6.20.2 Avimex Animal Health Description and Business Overview
6.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
6.20.5 Avimex Animal Health Recent Developments/Updates
6.21 MEVAC
6.21.1 MEVAC Company Information
6.21.2 MEVAC Description and Business Overview
6.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.21.4 MEVAC Veterinary Vaccine Product Portfolio
6.21.5 MEVAC Recent Developments/Updates
6.22 Biovac
6.22.1 Biovac Company Information
6.22.2 Biovac Description and Business Overview
6.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Biovac Veterinary Vaccine Product Portfolio
6.22.5 Biovac Recent Developments/Updates
6.23 Atafen
6.23.1 Atafen Company Information
6.23.2 Atafen Description and Business Overview
6.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Atafen Veterinary Vaccine Product Portfolio
6.23.5 Atafen Recent Developments/Updates
6.24 Dyntec
6.24.1 Dyntec Company Information
6.24.2 Dyntec Description and Business Overview
6.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Dyntec Veterinary Vaccine Product Portfolio
6.24.5 Dyntec Recent Developments/Updates
6.25 RVSRI
6.25.1 RVSRI Company Information
6.25.2 RVSRI Description and Business Overview
6.25.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.25.4 RVSRI Veterinary Vaccine Product Portfolio
6.25.5 RVSRI Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Vaccine Industry Chain Analysis
7.2 Veterinary Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Vaccine Production Mode & Process
7.4 Veterinary Vaccine Sales and Marketing
7.4.1 Veterinary Vaccine Sales Channels
7.4.2 Veterinary Vaccine Distributors
7.5 Veterinary Vaccine Customers
8 Veterinary Vaccine Market Dynamics
8.1 Veterinary Vaccine Industry Trends
8.2 Veterinary Vaccine Market Drivers
8.3 Veterinary Vaccine Market Challenges
8.4 Veterinary Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Veterinary Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Veterinary Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Veterinary Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Veterinary Vaccine Sales (M Doses) of Key Manufacturers (2019-2024)
 Table 5. Global Veterinary Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Veterinary Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Veterinary Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Veterinary Vaccine Average Price (USD/K Doses) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Veterinary Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
 Table 18. Global Veterinary Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global Veterinary Vaccine Sales by Region (2025-2030) & (M Doses)
 Table 20. Global Veterinary Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global Veterinary Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Veterinary Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global Veterinary Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Veterinary Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America Veterinary Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
 Table 27. North America Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
 Table 28. North America Veterinary Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Veterinary Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Veterinary Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
 Table 32. Europe Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
 Table 33. Europe Veterinary Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Veterinary Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Veterinary Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
 Table 37. Asia Pacific Veterinary Vaccine Sales by Region (2025-2030) & (M Doses)
 Table 38. Asia Pacific Veterinary Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Veterinary Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Veterinary Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
 Table 42. Latin America Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
 Table 43. Latin America Veterinary Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Veterinary Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Veterinary Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
 Table 47. Middle East and Africa Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
 Table 48. Middle East and Africa Veterinary Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Veterinary Vaccine Sales (M Doses) by Type (2019-2024)
 Table 51. Global Veterinary Vaccine Sales (M Doses) by Type (2025-2030)
 Table 52. Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global Veterinary Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global Veterinary Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Veterinary Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Veterinary Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global Veterinary Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global Veterinary Vaccine Price (USD/K Doses) by Type (2019-2024)
 Table 59. Global Veterinary Vaccine Price (USD/K Doses) by Type (2025-2030)
 Table 60. Global Veterinary Vaccine Sales (M Doses) by Application (2019-2024)
 Table 61. Global Veterinary Vaccine Sales (M Doses) by Application (2025-2030)
 Table 62. Global Veterinary Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global Veterinary Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global Veterinary Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Veterinary Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Veterinary Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global Veterinary Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global Veterinary Vaccine Price (USD/K Doses) by Application (2019-2024)
 Table 69. Global Veterinary Vaccine Price (USD/K Doses) by Application (2025-2030)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 73. Merck Veterinary Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Zoetis Company Information
 Table 76. Zoetis Description and Business Overview
 Table 77. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 78. Zoetis Veterinary Vaccine Product
 Table 79. Zoetis Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 83. Boehringer Ingelheim Veterinary Vaccine Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Ceva Company Information
 Table 86. Ceva Description and Business Overview
 Table 87. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 88. Ceva Veterinary Vaccine Product
 Table 89. Ceva Recent Developments/Updates
 Table 90. CAHIC Company Information
 Table 91. CAHIC Description and Business Overview
 Table 92. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 93. CAHIC Veterinary Vaccine Product
 Table 94. CAHIC Recent Developments/Updates
 Table 95. HVRI Company Information
 Table 96. HVRI Description and Business Overview
 Table 97. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 98. HVRI Veterinary Vaccine Product
 Table 99. HVRI Recent Developments/Updates
 Table 100. Ringpu Biology Company Information
 Table 101. Ringpu Biology Description and Business Overview
 Table 102. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 103. Ringpu Biology Veterinary Vaccine Product
 Table 104. Ringpu Biology Recent Developments/Updates
 Table 105. Yebio Company Information
 Table 106. Yebio Description and Business Overview
 Table 107. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 108. Yebio Veterinary Vaccine Product
 Table 109. Yebio Recent Developments/Updates
 Table 110. DHN Company Information
 Table 111. DHN Description and Business Overview
 Table 112. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 113. DHN Veterinary Vaccine Product
 Table 114. DHN Recent Developments/Updates
 Table 115. WINSUN Company Information
 Table 116. WINSUN Description and Business Overview
 Table 117. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 118. WINSUN Veterinary Vaccine Product
 Table 119. WINSUN Recent Developments/Updates
 Table 120. Elanco Company Information
 Table 121. Elanco Description and Business Overview
 Table 122. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 123. Elanco Veterinary Vaccine Product
 Table 124. Elanco Recent Developments/Updates
 Table 125. Virbac Company Information
 Table 126. Virbac Description and Business Overview
 Table 127. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 128. Virbac Veterinary Vaccine Product
 Table 129. Virbac Recent Developments/Updates
 Table 130. Jinyu Bio-Technology Company Information
 Table 131. Jinyu Bio-Technology Description and Business Overview
 Table 132. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 133. Jinyu Bio-Technology Veterinary Vaccine Product
 Table 134. Jinyu Bio-Technology Recent Developments/Updates
 Table 135. Medion Company Information
 Table 136. Medion Description and Business Overview
 Table 137. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 138. Medion Veterinary Vaccine Product
 Table 139. Medion Recent Developments/Updates
 Table 140. CAVAC Company Information
 Table 141. CAVAC Description and Business Overview
 Table 142. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 143. CAVAC Veterinary Vaccine Product
 Table 144. CAVAC Recent Developments/Updates
 Table 145. Kyoto Biken Laboratories Company Information
 Table 146. Kyoto Biken Laboratories Description and Business Overview
 Table 147. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 148. Kyoto Biken Laboratories Veterinary Vaccine Product
 Table 149. Kyoto Biken Laboratories Recent Developments/Updates
 Table 150. FATRO Company Information
 Table 151. FATRO Description and Business Overview
 Table 152. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 153. FATRO Veterinary Vaccine Product
 Table 154. FATRO Recent Developments/Updates
 Table 155. Vaksindo Company Information
 Table 156. Vaksindo Description and Business Overview
 Table 157. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 158. Vaksindo Veterinary Vaccine Product
 Table 159. Vaksindo Recent Developments/Updates
 Table 160. Bio-Labs Company Information
 Table 161. Bio-Labs Description and Business Overview
 Table 162. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 163. Bio-Labs Veterinary Vaccine Product
 Table 164. Bio-Labs Recent Developments/Updates
 Table 165. Avimex Animal Health Company Information
 Table 166. Avimex Animal Health Description and Business Overview
 Table 167. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 168. Avimex Animal Health Veterinary Vaccine Product
 Table 169. Avimex Animal Health Recent Developments/Updates
 Table 170. MEVAC Company Information
 Table 171. MEVAC Description and Business Overview
 Table 172. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 173. MEVAC Veterinary Vaccine Product
 Table 174. MEVAC Recent Developments/Updates
 Table 175. Biovac Company Information
 Table 176. Biovac Description and Business Overview
 Table 177. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 178. Biovac Veterinary Vaccine Product
 Table 179. Biovac Recent Developments/Updates
 Table 180. Atafen Company Information
 Table 181. Atafen Description and Business Overview
 Table 182. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 183. Atafen Veterinary Vaccine Product
 Table 184. Atafen Recent Developments/Updates
 Table 185. Dyntec Company Information
 Table 186. Dyntec Description and Business Overview
 Table 187. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 188. Dyntec Veterinary Vaccine Product
 Table 189. Dyntec Recent Developments/Updates
 Table 190. RVSRI Company Information
 Table 191. RVSRI Description and Business Overview
 Table 192. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
 Table 193. RVSRI Veterinary Vaccine Product
 Table 194. RVSRI Recent Developments/Updates
 Table 195. Key Raw Materials Lists
 Table 196. Raw Materials Key Suppliers Lists
 Table 197. Veterinary Vaccine Distributors List
 Table 198. Veterinary Vaccine Customers List
 Table 199. Veterinary Vaccine Market Trends
 Table 200. Veterinary Vaccine Market Drivers
 Table 201. Veterinary Vaccine Market Challenges
 Table 202. Veterinary Vaccine Market Restraints
 Table 203. Research Programs/Design for This Report
 Table 204. Key Data Information from Secondary Sources
 Table 205. Key Data Information from Primary Sources
 Table 206. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Vaccine
 Figure 2. Global Veterinary Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Veterinary Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Live Attenuated Vaccines Product Picture
 Figure 5. Inactivated Vaccines Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Veterinary Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Veterinary Vaccine Market Share by Application: 2023 & 2030
 Figure 9. Farm Animal
 Figure 10. Companion Animal
 Figure 11. Global Veterinary Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Veterinary Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Veterinary Vaccine Sales (2019-2030) & (M Doses)
 Figure 14. Global Veterinary Vaccine Average Price (USD/K Doses) & (2019-2030)
 Figure 15. Veterinary Vaccine Report Years Considered
 Figure 16. Veterinary Vaccine Sales Share by Manufacturers in 2023
 Figure 17. Global Veterinary Vaccine Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Veterinary Vaccine Players: Market Share by Revenue in Veterinary Vaccine in 2023
 Figure 19. Veterinary Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Veterinary Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Veterinary Vaccine Sales Market Share by Country (2019-2030)
 Figure 22. North America Veterinary Vaccine Revenue Market Share by Country (2019-2030)
 Figure 23. U.S. Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Veterinary Vaccine Sales Market Share by Country (2019-2030)
 Figure 26. Europe Veterinary Vaccine Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Greece Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Ukraine Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Moldova Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Albania Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Serbia Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Asia Pacific Veterinary Vaccine Sales Market Share by Region (2019-2030)
 Figure 38. Asia Pacific Veterinary Vaccine Revenue Market Share by Region (2019-2030)
 Figure 39. China Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Japan Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. South Korea Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. India Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Australia Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Taiwan Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Indonesia Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Thailand Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Malaysia Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Philippines Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Latin America Veterinary Vaccine Sales Market Share by Country (2019-2030)
 Figure 50. Mexico Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Brazil Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Argentina Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Middle East and Africa Veterinary Vaccine Sales Market Share by Country (2019-2030)
 Figure 54. Middle East and Africa Veterinary Vaccine Revenue Market Share by Country (2019-2030)
 Figure 55. Turkey Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. Saudi Arabia Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 57. U.A.E Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 58. Egypt Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 59. South Africa Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 60. Israel Veterinary Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 61. Global Sales Market Share of Veterinary Vaccine by Type (2019-2030)
 Figure 62. Global Revenue Market Share of Veterinary Vaccine by Type (2019-2030)
 Figure 63. Global Veterinary Vaccine Price (USD/K Doses) by Type (2019-2030)
 Figure 64. Global Sales Market Share of Veterinary Vaccine by Application (2019-2030)
 Figure 65. Global Revenue Market Share of Veterinary Vaccine by Application (2019-2030)
 Figure 66. Global Veterinary Vaccine Price (USD/K Doses) by Application (2019-2030)
 Figure 67. Veterinary Vaccine Value Chain
 Figure 68. Veterinary Vaccine Production Process
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners